NCT07509398 2026-04-03
FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer
Shanghai 10th People's Hospital
Phase 2/3 Not yet recruiting
Clinical Trials
5 trialsNCT07321847 2026-01-07
INJECTABL-3
Immunophotonics, Inc.
Phase 2/3 Not yet recruiting
NCT06719479 2024-12-05
A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 2/3 Not yet recruiting
NCT06337695 2024-04-02
VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer
University of Calgary
Phase 2/3 Not yet recruiting
NCT04890522 2021-05-18
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC
Sun Yat-sen University
Phase 2/3 Not yet recruiting